Clinical trial
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery…
NCT00316212 · Merck Sharp & Dohme LLC, Industry · Terminated
Key facts
| NCT number | NCT00316212 |
|---|---|
| Title | Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass |
| Official title | Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Coronary Disease |
| Intervention type | Drug |
| Interventions | INS50589 Intravenous Infusion |
| Enrollment | 160 |
| Start date | Apr 1, 2006 |
| Primary completion | Aug 1, 2006 |
| First posted | Apr 20, 2006 |
| Last update posted | Nov 18, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: